Zobrazeno 1 - 10
of 35
pro vyhledávání: '"P J, Bugelski"'
Publikováno v:
Diabetes, Obesity and Metabolism. 3:163-170
Rosiglitazone (BRL-49653-C), a thiazolidinedione, is a potent agonist for the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARgamma). Thiazolidinediones have been reported to induce adipocyte differentiation in vitro an
Autor:
P J Vance, Beth S. Haggarty, Celia C. LaBranche, T K Hart, M M Sauter, P J Bugelski, J Romano, Mark Marsh, James A. Hoxie
Publikováno v:
Journal of Virology. 69:5217-5227
We have described a virus termed CP-MAC, derived from the BK28 molecular clone of simian immunodeficiency virus, that was remarkable for its ability to infect Sup-T1 cells with rapid kinetics, cell fusion, and CD4 down-modulation (C. C. LaBranche, M.
Publikováno v:
Toxicology in Vitro. 13:567-569
Alamar Blue (AB) reduction is a promising new in vitro assay which is simple to conduct and amenable to repeated measurements and high-throughput screening; however, evaluation with hepatocytes has not been reported. Accordingly, we compared AB reduc
Autor:
K. A. Rudnick, A. Volk, R. Tawadros, P. J. Bugelski, S. H. Tam, J. Yang, G. M. Anderson, L. A. Snyder
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 6(2)
Summary. Background: Tissue factor (TF) is expressed widely at the subluminal surface of blood vessels and serves as the primary cellular initiator of the extrinsic pathway of blood coagulation. Lack of TF in mice resulted in lethality in utero, but
Publikováno v:
Humanexperimental toxicology. 21(9-10)
Keliximab is a human-cynomolgus monkey chimeric (Primatized) monoclonal antibody with specificity for human and chimpanzee CD4. As the preclinical safety assessment of biopharmaceuticals requires evaluation in pharmacologically responsive species, co
Publikováno v:
Diabetes, obesitymetabolism. 3(3)
Rosiglitazone (BRL-49653-C), a thiazolidinedione, is a potent agonist for the nuclear hormone receptor peroxisome proliferator-activated receptor gamma (PPARgamma). Thiazolidinediones have been reported to induce adipocyte differentiation in vitro an
Publikováno v:
Pharmaceutical research. 17(10)
Recent advances in combinatorial chemistry and high throughput screens for pharmacologic activity have created an increasing demand for in vitro high throughput screens for toxicological evaluation in the early phases of drug discovery.To develop a s
Autor:
F Elcock, J M Birmingham, Peter J. O'Brien, P J Bugelski, A Swain, Mark R Slaughter, R W Greenhill
Publikováno v:
Humanexperimental toxicology. 19(5)
Repeated dosing of acetaminophen (paracetamol) to rats is reported to decrease their sensitivity to its hepatotoxic effects, which are associated with oxidative stress and glutathione depletion. We determined if repeated acetaminophen dosing produced
Autor:
P J Bugelski, D M Williams, T K Hart, Danuta J. Herzyk, S Rehm, Richard A. Macia, Allen G. Harmsen, A. Truneh, D G Morgan, E V Gore, A M Badger, B E Maleeff, Patrick J. Wier, S R O'Brien
Publikováno v:
Humanexperimental toxicology. 19(4)
The preclinical safety assessment of biopharmaceuticals necessitates that studies be conducted in species in which the products are pharmacologically active. Monoclonal anti-bodies are a promising class ofbiopharmaceuticals for many disease indicatio
Autor:
T W, Hepburn, C B, Davis, J J, Urbanski, B R, Smith, W H, Schaefer, M A, Carbonaro, P J, Bugelski
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 23(10)
Recombinant soluble CD4 (sT4; mol. wt. 45,000) has been studied extensively in Sprague-Dawley rats, and substantial renal processing has been indicated. In rats and monkeys, renal filtration and precipitation of sT4 in the distal nephron caused tubul